Varia Ventures

MimiVax, LLC is a clinical-stage biotechnology company based in Buffalo, New York, focused on developing immunotherapeutic vaccines and targeted therapies for cancer treatment. Founded in 2011, the company specializes in creating vaccines that utilize survivin-targeting technology, which aims to disrupt a cell-survival protein commonly found in various cancers. Its lead product, SurVaxM, is a peptide mimic immunotherapeutic vaccine designed to control tumor growth and recurrence, enhancing the potential for patient survival. Through its innovative approach, MimiVax seeks to provide healthcare providers with effective tools to improve cancer treatment outcomes.

Buffalo Automation is a company specializing in autonomous navigation technology for both commercial and recreational boating. The firm develops AutoMate, a self-piloting system that autonomously steers and docks vessels. This technology integrates computer hardware, software, and sensors, utilizing standard maritime communications protocols to provide boaters with real-time information about their heading, obstacles, engine status, and navigational conditions. Through its innovative solutions, Buffalo Automation aims to enhance safety and efficiency in maritime operations.